Renowned for its picturesque landscapes and vital freshwater resources, the mountainous regions of Greece are confronting a stark environmental transformation…

In an era where healthcare systems face relentless pressure due to aging populations and the rising complexity of medical conditions,…

In a groundbreaking study published in the prestigious journal Gene Therapy, researchers have unveiled intricate details about the behavior of…

In a groundbreaking nationwide study published in the British Journal of Cancer this April, researchers have unveiled compelling evidence linking…

In a groundbreaking advance poised to transform emergency medicine and regenerative therapies, researchers have unveiled engineered blood clots (EBCs) that…

BeOne Medicines is paying $20 million upfront to reserve the right to buy a preclinical trispecific antibody from China’s Huahui Health.  The antibody,…

Danish dermatology specialist Leo Pharma is paying $50 million for U.S. gene writing biotech Replay and its preclinical gene therapy…

GSK and Alector have stopped a phase 2 trial of their Alzheimer’s disease drug candidate after an interim analysis found the…

Avalyn Pharma has overshot its expectations with a $300 million IPO that the biotech will use to fund late-stage studies…

In a groundbreaking study published in Nature, researchers have unveiled a striking discovery that redefines our understanding of diabetic kidney…